5-Hydroxytryptamine Receptor 2B, Pipeline Review, H2 2019: AnaMar AB, INVENT Pharmaceuticals Inc & Seropeutics LLC ...
(WorldNews Business)

DUBLIN--(BUSINESS WIRE)--Jan 21, 2020-- The `5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2019` drug pipelines has been added to ResearchAndMarkets.com`s offering. Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report 5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2019, outlays comprehensive information on the 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics, complete with analysis by indications, stage of development,...